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Abstract 
    The effects of androgens on gonadotropin-releasing hormone (GnRH) secretion in 
females have not been fully established. To clarify the direct effects of androgens on 
hypothalamic reproductive factors, we evaluated the effects of chronic testosterone 
administration on hypothalamic GnRH regulatory factors in ovariectomized (OVX) 
female rats. Both testosterone and estradiol reduced the serum luteinizing hormone levels 
of OVX female rats, indicating that, as has been found for estrogen, testosterone 
suppresses GnRH secretion via negative feedback. Similarly, the administration of 
testosterone or estradiol suppressed the hypothalamic mRNA levels of kisspeptin and 
neurokinin B, both of which are positive regulators of GnRH, whereas it did not affect 
the hypothalamic mRNA levels of the kisspeptin receptor or neurokinin 3 receptor. On 
the contrary, the administration of testosterone, but not estradiol, suppressed the 
hypothalamic mRNA expression of prodynorphin, which is a negative regulator of GnRH. 
The administration of testosterone did not alter the rats’ serum estradiol levels, indicating 
that testosterone’s effects on hypothalamic factors might be induced by its androgenic 
activity. These findings suggest that as well as estrogen, androgens have negative 
feedback effects on GnRH in females and that the underlying mechanisms responsible 
for these effects are similar, but do not completely correspond, to the mechanisms 
underlying the effects of estrogen on GnRH. 
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Introduction 
    Reproductive functions are mainly regulated by the neuroendocrine system, which 
is known as the hypothalamic-pituitary-gonadal axis (HPG axis). Gonadotropin-releasing 
hormone (GnRH) functions as a central regulator of the HPG axis through its stimulatory 
effects on gonadotropin secretion. In the early 21st century, it was clarified that GnRH 
production/secretion is regulated by hypothalamic neuropeptides. Kisspeptin and its 
receptor (Kiss1r) act as positive regulators of GnRH, whereas RFamide-related 
peptides/gonadotropin inhibitory hormone (RFRP/GnIH) and its receptor G protein-
coupled receptor (GPR)147 function as inhibitory regulators [1-3]. In addition, in 2007 it 
was shown that neurokinin B (NKB) and dynorphin (Dyn) co-localize with kisspeptin in 
the same neuronal populations, and therefore, these neurons are termed KNDy neurons 
[4,5]. NKB stimulates the activity of KNDy neurons, predominantly via its receptor 
tachykinin receptor 3 and increases GnRH secretion [6,7]. On the other hand, Dyn inhibits 
KNDy neurons and/or GnRH neurons via the kappa opioid receptor (KOR), which in turn 
reduces GnRH secretion [6,8]. Interestingly, although kisspeptin is found in two 
hypothalamic nuclei, the anteroventral periventricular nucleus (AVPV) and arcuate 
nucleus (ARC), its co-localization with NKB and Dyn is only observed in the ARC [6,9]. 
    It has been well established that estrogen plays pivotal roles in the regulation of 
GnRH secretion via feedback effects on hypothalamic kisspeptin and RFRP/GnIH 
expression. Estrogen suppresses kisspeptin and NKB release from KNDy neurons in the 
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ARC [6], and Kiss1 (the kisspeptin encoding gene) and NKB mRNA expression are 
upregulated and prodynorphin (pDYN) mRNA expression is downregulated in 
postmenopausal women and ovariectomized animals [9,10-12]. In addition, the 
administration of estradiol was found to alter the activity or mRNA expression of 
RFRP/GnIH [13,14], although the direction of such changes varies depending on the 
experimental model. These changes might be related to the negative feedback effects of 
estrogen on GnRH. On the other hand, estrogen increases kisspeptin release in the AVPV, 
and the neuronal activity of RFRP/GnIH is decreased during the pre-ovulatory GnRH 
surge [6,15]. Therefore, these alterations are involved in the positive feedback effects of 
estrogen on GnRH. 
    In contrast to estrogen, the effects of androgens on GnRH secretion in females have 
not been fully established. Almost all of the previous studies that investigated the effects 
of androgens on female physiological functions used animal models of polycystic ovary 
syndrome (PCOS), which is a representative hyperandrogenism-related disorder [16]. 
Recently, we and other groups have investigated hypothalamic kisspeptin and/or Kiss1 
mRNA levels, as well as serum gonadotropin levels, in PCOS model rodents; however, 
there were marked discrepancies between the results of these studies [17-19]. As ovary-
intact rodents were used to produce the PCOS models, androgen-induced changes in 
ovarian functions might have affected their hypothalamic functions, which could explain 
the discrepancies among the studies’ results. Therefore, examinations performed under 
stable conditions are needed to clarify the effects of androgens on hypothalamic 
reproductive factors. 
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    In this study, to determine the direct effects of androgens on hypothalamic 
reproductive factors, we evaluated the influence of chronic testosterone administration on 
hypothalamic GnRH regulatory factors under ovariectomized (OVX) conditions. We also 
assessed the effects of chronic estradiol administration on these factors, and compared 
them with testosterone’s effects. In addition, we measured the serum leptin level because 
it has been reported that leptin plays some roles in the regulation of hypothalamic GnRH 
regulatory factors and that the gonadal steroidal milieu affects the serum leptin level 
[20,21]. 
 
Materials and Methods 
Animals 
    Eight-week-old female adult Wistar rats (200-230 g) were purchased from Charles 
River Laboratories Japan, Inc. (Kanagawa, Japan) and housed in a room under controlled 
light (12 h light, 12 h darkness; lights turned on at 0800 and turned off at 2000) and 
temperature (24°C) conditions. In total, 24 rats were used in this study, and all animal 
experiments were conducted in accordance with the ethical standards of the institutional 
animal care and use committee of the University of Tokushima. All surgical procedures 
were carried out under sodium pentobarbital- (60-80 mg/kg, intraperitoneal, i.p.) or 
sevoflurane-induced anesthesia. 
Testosterone/estradiol administration and tissue sampling 
    At nine weeks of age, the rats were bilaterally OVX and housed individually after 
the surgery. Four weeks after the ovariectomy procedure (13 weeks of age), the rats were 
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randomly divided into untreated (OVX), testosterone-administered (OVX-T), and 
estradiol-administered (OVX-E) groups. In the estradiol-administered group, a silastic 
tube filled with crystalline estradiol (length of the filled part, 3 mm) was subcutaneously 
implanted into each rat [22]. Similarly, in the testosterone-administered group, a silastic 
tube filled with crystalline testosterone was subcutaneously implanted into each rat 
(length of the filled part, 30 mm) [23]. At 16 days after the implantation procedure, the 
rats were sacrificed by decapitation, and their brain and blood were collected. The rats’ 
serum was separated by centrifugation and stored at -20°C, and their tissues were stored 
at -80°C. 
Hormone assay 
    The serum luteinizing hormone (LH) level was measured using a radioimmunoassay 
(rLH [I-125] RIA kit, Institute of Isotopes Co., Ltd., Tokyo, Japan). The sensitivity of the 
assay was 0.8 ng/ml, and the inter- and intra-assay coefficients of variation (CV) were 
7.7% and 6.5%, respectively. The serum leptin level was measured using 
radioimmunoassay kits (multi-species leptin RIA kit, Linco Research Inc., MO, USA). 
The sensitivity of the assay was 1.0 ng/ml, and its inter- and intra-assay CV were 3.2% 
and 7.8%, respectively. 
Quantitative real-time polymerase chain reaction 
    Whole hypothalamic explants were dissected from the frozen brains, as described 
previously [24]. Briefly, the brain sections were dissected out via an anterior coronal cut 
at the posterior border of the mammillary bodies, parasagittal cuts along the hypothalamic 
fissures, and a dorsal cut 2.5 mm from the ventral surface. Total RNA was isolated from 
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the hypothalamic explants and visceral fat using a TRIzol® reagent kit (Invitrogen Co., 
Carlsbad, CA, USA) and an RNeasy® mini kit (Qiagen GmbH, Hilden, Germany). cDNA 
was synthesized with oligo (deoxythymidine) primers at 50°C using the SuperScript III 
first-strand synthesis system for the real-time polymerase chain reaction (PCR; Invitrogen 
Co.). The PCR analysis was performed using the StepOnePlusTM real-time PCR system 
(PE Applied Biosystems, Foster City, CA, USA) and FAST SYBR® green. The 
hypothalamic mRNA levels of GnRH, Kiss1, Kiss1r, NKB, NK3R (the neurokinin 3 
receptor encoding gene), pDyn, Oprk1 (the KOR encoding gene), RFRP/GnIH, and 
GPR147 were measured. The mRNA expression level of each factor was normalized to 
that of GAPDH. The primer sequences, product sizes, and annealing temperatures are 
shown in Table 1. The PCR conditions were as follows: initial denaturation and enzyme 
activation were performed at 95°C for 20 s, followed by 45 cycles of denaturation at 95°C 
for 3 s, and annealing and extension for 30 s. 
Statistical analyses 
    All data are presented as the mean ± standard error (SE). The statistical analyses 
were performed using one-way analysis of variance (ANOVA) together with Dunnett’s 
test for multiple comparisons among the groups. Statistical significance was defined as P 
<0.05. 
 
Results 
Effects of testosterone/estradiol administration on serum LH and leptin levels 
    The serum testosterone level of the OVX-T group was higher than those of the other 
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groups, and the serum estradiol level of the OVX-E group was higher than those of the 
other groups, indicating that the steroids were successfully administered (Figs. 1A and B). 
The rats’ serum LH levels were altered by the administration of the steroids (one-way 
ANOVA, F(2,23) = 76.7; P <0.01). The serum LH levels of the OVX-T and OVX-E 
groups were lower than that of the OVX group (Fig. 1C). Similarly, the rats’ serum leptin 
levels were changed by the administration of the steroids (one-way ANOVA, F(2,23) = 
7.41; P <0.01). The serum leptin level of the OVX-E group was significantly lower than 
that of the OVX group (Fig. 1D).  
Effects of testosterone/estradiol administration on the mRNA levels of hypothalamic 
reproductive factors 
    The rats’ hypothalamic Kiss1 mRNA levels were altered by the administration of the 
steroids (one-way ANOVA, F(3,23) = 103.4; P <0.01). The hypothalamic Kiss1 mRNA 
levels of the OVX-T and OVX-E groups were lower than that of the OVX group (Fig. 
2B). The administration of the steroids also changed the rats’ hypothalamic NKB mRNA 
levels (one-way ANOVA, F(2,23) = 15.6; P <0.01), whereas it did not affect their 
hypothalamic Kiss1r mRNA levels (Fig. 2C). The hypothalamic NKB mRNA levels of 
the OVX-T and OVX-E groups were lower than that of the OVX group (Fig. 2D). The 
administration of testosterone, but not estradiol, altered the rats’ hypothalamic pDYN 
mRNA levels (one-way ANOVA, F(2,23) = 6.93; P <0.01), but neither steroid affected 
their hypothalamic NK3R mRNA levels (Fig. 2E). The hypothalamic pDYN mRNA level 
of the OVX-T group was lower than that of the OVX group (Fig. 2G). The administration 
of estradiol, but not testosterone, altered the rats’ hypothalamic RFRP mRNA levels (one-
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way ANOVA, F(2,23) = 8.09; P <0.01), whereas neither steroid affected their 
hypothalamic Oprk1 mRNA levels (Fig. 2H). The hypothalamic RFRP/GnIH mRNA 
level of the OVX-E group was lower than that of the OVX group (Fig. 2I). The rats’ 
hypothalamic GPR147 mRNA levels were not affected by the administration of the 
steroids (Fig. 2J). 
 
Discussion 
    It has been well established that estrogen plays pivotal roles in the regulation of 
GnRH secretion via feedback effects on hypothalamic GnRH-regulating factors [6]. On 
the other hand, the effects of androgens on GnRH secretion and the mechanisms 
underlying these effects in females have not been fully established. Thus, we evaluated 
the effects of chronic testosterone, one of the most important androgens, administration 
on gonadotropin secretion and hypothalamic GnRH regulatory factors in the present study. 
As a result, we found that testosterone administration reduced the serum LH levels of 
OVX female rats, indicating that testosterone suppresses GnRH secretion via its negative 
feedback effects in females. As the serum estradiol level was not increased by the 
administration of testosterone, the suppressive effect of testosterone on GnRH/LH might 
be based on the androgenic effects of testosterone, rather than the estrogenic effects of 
estrogen produced from testosterone. As noted above, it has been reported that GnRH 
secretion is positively and negatively regulated by various hypothalamic factors [6,9-14] 
and that the feedback effects of sex steroid hormones on GnRH are mediated by these 
factors [6,13,15]. Therefore, we also examined the effects of testosterone administration 
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on these factors in order to investigate the underlying mechanisms responsible for their 
negative feedback effects on GnRH. As a result, we found that both testosterone and 
estradiol suppressed the hypothalamic mRNA levels of Kiss1 and NKB, whereas they did 
not affect the hypothalamic mRNA levels of Kiss1r or NK3R. As NKB simulates the 
activity of kisspeptin (KNDy) neurons and increases GnRH secretion, reductions in NKB 
and Kiss1 mRNA expression might be involved in the negative feedback effects of 
testosterone and estradiol on GnRH/LH seen in this study. Recently, it has been reported 
that hypothalamic kisspeptin neurons express the androgen receptor and that the numbers 
of Kiss1-expressing and NKB-immunoreactive cells were decreased by 
dihydrotestosterone, which is a non-aromatizable androgen, in female rats [25]. Therefore, 
it can be assumed that the suppression of NKB and Kiss1 mRNA expression observed in 
the testosterone-administered rats was induced by the androgenic actions of testosterone. 
On the contrary, the effects of testosterone on hypothalamic RFRP and pDyn mRNA 
expression did not correspond with those of estradiol in the current study. Testosterone 
did not affect RFRP mRNA expression, whereas estradiol decreased it. It has been 
reported that RFRP neurons express the estrogen receptor-α, but not the androgen receptor, 
in both male and female mice and that estradiol reduces the RFRP mRNA levels of OVX 
female mice [14]. On the other hand, as far as we know, the effects of testosterone on Dyn 
expression in females have not been examined, and the effects of estradiol on Dyn 
expression varied markedly among previous studies [12,26]. Some studies found that 
ovariectomy or the menopause downregulated pDyn mRNA expression, and others 
suggested that the administration of estradiol reduced the number of Dyn-expressing cells. 
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Differences in the experimental protocols, animal models, and doses of estradiol might 
have contributed to these discrepancies. We speculate that the estradiol and testosterone-
induced reductions in the hypothalamic mRNA levels of RFRP and pDyn, respectively, 
observed in the present study might represent a counter-regulatory mechanism for 
preventing the excessive suppression of GnRH release via negative feedback effects. In 
this study, we also measured the serum levels of leptin, which is an anorexigenic 
adipocytokine, because it has been reported that leptin stimulates kisspeptin neurons and 
increases GnRH secretion in experimental animals [20]. Consequently, we found that the 
serum leptin level was reduced by the administration of estradiol, and this change might 
have been partially related to the reduction in the hypothalamic Kiss1 mRNA level. 
    As noted above, the current study revealed that testosterone itself has suppressive 
effects on hypothalamic Kiss1 mRNA levels. On the other hand, there were marked 
discrepancies between the results of previous studies that examined the effects of 
androgens on hypothalamic kisspeptin and/or Kiss1 mRNA levels in PCOS model rodents 
[17-19]. We assumed that one of the causes of these discrepancies was the differences 
between animal models (species and age at androgen treatment) and the kinds of 
androgens administered (testosterone, dihydrotestosterone, or dehydroepiandrosterone). 
We also assumed that the interactions between endogenous estrogens and the 
administered androgens might have changed their effects on hypothalamic GnRH 
regulatory factors. Further examinations are needed to clarify the physiological roles of 
androgens in females under physiological hormonal conditions. 
    In summary, as well as estradiol, chronic testosterone administration reduced the 
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serum levels of LH, indicating that testosterone has negative feedback effects on GnRH 
in females. Both testosterone and estradiol suppressed hypothalamic Kiss1 and NKB 
mRNA expression, whereas they did not affect the hypothalamic mRNA levels of Kiss1r 
of NK3R. The administration of testosterone did not alter the serum estradiol level, 
indicating that testosterone’s effects on hypothalamic factors might be induced by its 
androgenic activity. On the contrary, the effects of testosterone on hypothalamic RFRP 
and pDyn mRNA expression did not correspond with those of estradiol. These findings 
indicate that the underlying mechanisms responsible for the negative feedback effects of 
testosterone on GnRH are similar, but do not completely correspond, to the mechanisms 
underlying the effects of estrogen. 
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Figure legends 
Fig. 1 
(A) Serum testosterone, (B) estradiol, (C) LH, and (D) leptin levels of the OVX, OVX-T, 
and OVX-E groups 
 Data are expressed as mean ± SE values. ** P <0.01 vs. OVX; UD: undetectable  
 
Fig. 2 
(A-I) Hypothalamic GnRH, Kiss1, Kiss1r, NKB, NK3R, pDyn, Oprk1, RFRP, and 
GPR147 mRNA levels of the OVX, OVX-T, and OVX-E groups 
 Data are expressed as mean ± SE values. All mRNA expression levels were normalized 
to the mRNA expression level of GAPDH, and the values of the OVX group were defined 
as 1.0. **P <0.01 vs. OVX 
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Primer Sequence Product size (bp) Annealing T (℃)
GnRH forward GCA GAA CCC CAG AAC TTC GA 101 64
GnRH reverse TGC CCA GCT TCC TCT TCA AT 
Kiss1 forward ATG ATC TCG CTG GCT TCT TGG 91 65
Kiss1 reverse GGT TCA CCA CAG GTG CCA TTT T 
Kiss1r forward TGT GCA AAT TCG TCA ACT ACA TCC 193 65
Kiss1r reverse AGC ACC GGG GCG GAA ACA GCT GC 
NKB forward GGG ACC GAA GGA GAC ATC ACT 71 63
NKB reverse TCT TGC CCA TAA GTC CCA CAA
NK3R forward AGC GGT GTT TGC CAG CAT 76 63
NK3R reverse TTT CAA CGG ATC AAT AAT AGC CAT AT
pDyn forward GTT CCC TGT GTG CAG TGA GGA C 418 64
pDyn reverse TAG CGT TTG GCC TGT TTT CTC A
Oprk1 forward GAT GTC ATT GAA TGC TCC TTG C 138 60
Oprk1 reverse CAG GAT CAT CAG GGT GTA GCA G
RFRP forward GAG TCC TGG TCA AGA GCA AC 93 60
RFRP reverse ACT GGC TGG AGG TTT CCTA T 
GPR147 forward GTG TCT GCA TCG GTT TTC AC 92 60
GPR147 reverse TTC CGA AGG GTC AGC TTC 
GAPDH forward ATG GCA CAG TCA AGG CTG AGA 64 70
GAPDH reverse CGC TCC TGG AAG ATG GTG AT
Table 1    Primer sequences, product sizes and annealing temperature. 
